Cargando…
Timing of mTOR activation affects tuberous sclerosis complex neuropathology in mouse models
Tuberous sclerosis complex (TSC) is a dominantly inherited disease with high penetrance and morbidity, and is caused by mutations in either of two genes, TSC1 or TSC2. Most affected individuals display severe neurological manifestations – such as intractable epilepsy, mental retardation and autism –...
Autores principales: | Magri, Laura, Cominelli, Manuela, Cambiaghi, Marco, Cursi, Marco, Leocani, Letizia, Minicucci, Fabio, Poliani, Pietro Luigi, Galli, Rossella |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Company of Biologists Limited
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3759338/ https://www.ncbi.nlm.nih.gov/pubmed/23744272 http://dx.doi.org/10.1242/dmm.012096 |
Ejemplares similares
-
Temporal evolution of neurophysiological and behavioral features of synapsin I/II/III triple knock-out mice
por: Cambiaghi, Marco, et al.
Publicado: (2013) -
mTOR Inhibitors in Tuberous Sclerosis Complex
por: Curatolo, Paolo, et al.
Publicado: (2012) -
Targeting mTOR Pathway in PTEN Deleted Newly Isolated Chordoma Cell Line
por: Pagani, Francesca, et al.
Publicado: (2023) -
Raptor Preys on mTOR Imbalance in Tuberous Sclerosis
por: Ramamurthy, Aishwarya, et al.
Publicado: (2023) -
Is mTOR inhibition a systemic treatment for tuberous sclerosis?
por: Moavero, Romina, et al.
Publicado: (2013)